Shares of Ardent Health, Inc. (NYSE:ARDT – Get Free Report) have earned an average rating of “Hold” from the fifteen ratings firms that are currently covering the company, MarketBeat reports. Two analysts have rated the stock with a sell recommendation, six have issued a hold recommendation and seven have assigned a buy recommendation to the company. The average twelve-month price target among brokers that have issued ratings on the stock in the last year is $12.79.
A number of research analysts have weighed in on ARDT shares. Royal Bank Of Canada raised their target price on shares of Ardent Health from $12.00 to $13.00 and gave the stock an “outperform” rating in a research note on Monday, August 10th. Wall Street Zen downgraded Ardent Health from a “buy” rating to a “hold” rating in a research report on Sunday, July 12th. Weiss Ratings cut shares of Ardent Health from a “sell (d+)” rating to a “sell (d)” rating in a research report on Tuesday, August 11th. Truist Financial raised their target price on Ardent Health from $12.00 to $13.00 and gave the company a “buy” rating in a report on Thursday, August 6th. Finally, The Goldman Sachs Group reaffirmed a “neutral” rating and set a $13.00 price objective on shares of Ardent Health in a research report on Thursday, August 6th.
Read Our Latest Stock Analysis on Ardent Health
Institutional Trading of Ardent Health
Ardent Health Trading Down 2.2%
Shares of Ardent Health stock opened at $10.35 on Friday. The company has a current ratio of 2.10, a quick ratio of 1.99 and a debt-to-equity ratio of 0.61. The firm’s 50-day moving average price is $10.87 and its 200 day moving average price is $9.98. The firm has a market capitalization of $1.46 billion, a PE ratio of 18.81, a P/E/G ratio of 2.99 and a beta of 0.71. Ardent Health has a twelve month low of $7.71 and a twelve month high of $15.48.
Ardent Health (NYSE:ARDT – Get Free Report) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.18 by ($0.06). Ardent Health had a return on equity of 10.35% and a net margin of 1.22%.The firm had revenue of $1.62 billion for the quarter, compared to analysts’ expectations of $1.59 billion. Ardent Health has set its FY 2026 guidance at 0.780-1.150 EPS. On average, sell-side analysts predict that Ardent Health will post 0.96 EPS for the current fiscal year.
About Ardent Health
Ardent Health is a U.S. healthcare provider that owns and operates hospitals, outpatient facilities and other healthcare services. The company delivers a broad range of medical care, including emergency services, inpatient and outpatient treatment, primary care, specialty care, surgical services, behavioral health and urgent care.
Headquartered in Nashville, Tennessee, Ardent serves communities through a network of hospitals and healthcare sites in several states, including Texas, Oklahoma, New Mexico and Kansas.
Featured Stories
- Five stocks we like better than Ardent Health
- Deutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?
- O’Reilly Automotive’s Stock Slump Hides a Stronger Business
- McDonald’s Stock Slump Makes Its AI Pricing Bet Even Riskier
- Broadcom’s AI Growth Story Faces a $161 Billion Anthropic Test
Receive News & Ratings for Ardent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health and related companies with MarketBeat.com's FREE daily email newsletter.
